Clinical Trial Update: Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an etodolac-lidocaine patch for acute delayed onset muscle soreness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Onset Muscle Soreness

Drugs mentioned

• Etodolac-lidocaine patch (etodolac-lidocaine combination patch)

Snippet

Sponsor: MEDRx USA, Inc. | Conditions: Acute Delayed Onset Muscle Soreness (DOMS) | Phase 3 | Status: COMPLETED